Carmine Gentile's Biography

Carmine Gentile, Lecturer in the School of Biomedical Engineering, University of Technology Sydney

Dr Carmine Gentile, PharmD/PhD, FAHA, is a Lecturer within the School of Biomedical Engineering at the University of Technology Sydney (UTS) and leads the Cardiovascular Regeneration Group both at UTS and at the University of Sydney. He received his BSc, MSc and PharmD at the University of Pisa, Italy and his PhD at the Medical University of South Carolina, Charleston, SC, USA, funded by a prestigious American Heart Association Fellowship. Since 2013 Dr Gentile has worked in Australia supported by several awards and grants, working within a multidisciplinary team with scientists, industry partners and clinicians to quickly translate his findings from bench to bedside. Dr Gentile is an internationally recognized expert in the field of 3D bioprinting and stem cell technologies and his more recent studies focus on novel molecular and cellular approaches to treat cardiovascular disease, including myocardial infarction and heart failure. These studies are based on the use of “mini-hearts” he developed as “bioinks” for human heart tissues. In 2016, he was invited as Visiting Research Fellow at Harvard Medical School, where he worked towards novel in vitro models using mini-hearts to study human heart physiology. His research received media attention and featured on ABC News (2016), ABC Catalyst (2017), Sydney TEDx (2018), Daily Telegraph (2019) and Channel 7News (2020).